General MedicationsOPHTHALMICGeneric
VEXOL
RIMEXOLONE
Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview VEXOL is listed in Drugs@FDA under application 020474 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient RIMEXOLONE Form and strength SUSPENSION/DROPS;OPHTHALMIC - 1% Sponsor HARROW EYE Submission history Latest submission status date: 2012-02-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview VEXOL is listed in Drugs@FDA under application 020474 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient RIMEXOLONE Form and strength SUSPENSION/DROPS;OPHTHALMIC - 1% Sponsor HARROW EYE Submission history Latest submission status date: 2012-02-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.